Cellectricon Receives Swedish Governmental R&D; Grant

Friday, September 22, 2006 Print

Cellectricon has received a grant totaling SEK 2.3 million from VINNOVA (The Swedish Governmental Agency for Innovation Systems).

The VINNOVA grant was awarded for the development of Cellectricon's next generation microfluidics platform for high-resolution GPCR screening.

"The VINNOVA grant validates the potential of Cellectricon's unique miniaturized cell-based screening systems for drug discovery", says Dr. Mattias Karlsson, Chief Operating Officer at Cellectricon.

"The market acceptance of our launched products together with the VINNOVA grant is gratifying and we will continue to focus on providing innovative solutions for our customers."